Literature DB >> 20801235

Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction.

Beate Fuchs1, Natascha Sommer, Alexander Dietrich, Ralph Theo Schermuly, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Werner Seeger, Thomas Gudermann, Norbert Weissmann.   

Abstract

Hypoxic pulmonary vasoconstriction (HPV) is an essential physiological mechanism of the lung that matches blood perfusion with alveolar ventilation to optimize gas exchange. Perturbations of HPV, as may occur in pneumonia or adult respiratory distress syndrome, can cause life-threatening hypoxemia. Despite intensive research for decades, the molecular mechanisms of HPV have not been fully elucidated. Reactive oxygen species (ROS) and changes in the cellular redox state are proposed to link O2 sensing and pulmonary arterial smooth muscle cell contraction underlying HPV. In this regard, mitochondria and NAD(P)H oxidases are discussed as sources of ROS. However, there is controversy whether ROS levels decrease or increase during hypoxia. With this background we summarize the current knowledge on the role of ROS and redox state in HPV.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801235     DOI: 10.1016/j.resp.2010.08.013

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  23 in total

Review 1.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Copper response regulator1-dependent and -independent responses of the Chlamydomonas reinhardtii transcriptome to dark anoxia.

Authors:  Anja Hemschemeier; David Casero; Bensheng Liu; Christoph Benning; Matteo Pellegrini; Thomas Happe; Sabeeha S Merchant
Journal:  Plant Cell       Date:  2013-09-06       Impact factor: 11.277

Review 3.  Lung cell hypoxia: role of mitochondrial reactive oxygen species signaling in triggering responses.

Authors:  Paul T Schumacker
Journal:  Proc Am Thorac Soc       Date:  2011-11

4.  Hypoxia inhibits expression and function of mitochondrial thioredoxin 2 to promote pulmonary hypertension.

Authors:  Sherry E Adesina; Brandy E Wade; Kaiser M Bijli; Bum-Yong Kang; Clintoria R Williams; Jing Ma; Young-Mi Go; C Michael Hart; Roy L Sutliff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

5.  Reactive oxygen species effect PASMCs apoptosis via regulation of dynamin-related protein 1 in hypoxic pulmonary hypertension.

Authors:  Lixin Zhang; Cui Ma; Chen Zhang; Mingfei Ma; Fengying Zhang; Linlin Zhang; Yingli Chen; Fangyuan Cao; Shuzhen Li; Daling Zhu
Journal:  Histochem Cell Biol       Date:  2016-03-24       Impact factor: 4.304

6.  Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide.

Authors:  Liping Ye; Juan Liu; Huixia Liu; Lei Ying; Dou Dou; Zhengju Chen; Xiaojian Xu; J Uhsa Raj; Yuansheng Gao
Journal:  Pflugers Arch       Date:  2012-11-10       Impact factor: 3.657

Review 7.  NADPH oxidases-do they play a role in TRPC regulation under hypoxia?

Authors:  Monika Malczyk; Christine Veith; Ralph T Schermuly; Thomas Gudermann; Alexander Dietrich; Natascha Sommer; Norbert Weissmann; Oleg Pak
Journal:  Pflugers Arch       Date:  2015-10-01       Impact factor: 3.657

Review 8.  Oxidative modulation of voltage-gated potassium channels.

Authors:  Nirakar Sahoo; Toshinori Hoshi; Stefan H Heinemann
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 9.  Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Antioxid Redox Signal       Date:  2012-08-20       Impact factor: 8.401

Review 10.  O2 sensing, mitochondria and ROS signaling: The fog is lifting.

Authors:  Gregory B Waypa; Kimberly A Smith; Paul T Schumacker
Journal:  Mol Aspects Med       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.